REPLIGEN CORP vs Acumen Pharmaceuticals, Inc., risk disclosures compared

4topics both disclose

7only REPLIGEN CORP

0only Acumen Pharmaceuticals, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	REPLIGEN CORP	Acumen Pharmaceuticals, Inc.
Internal Control	15	2
Restatement	14	3
Material Weakness	5	1
Enforcement Action	2	2

Only REPLIGEN CORP

Topic	Filings
Business Continuity	10
Cybersecurity Incident	8
Ransomware	6
Audit Committee Oversight	5
Consent Order	2
AI Governance	1
Data Breach	1

Only Acumen Pharmaceuticals, Inc.

Nothing.

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

REPLIGEN CORP · Acumen Pharmaceuticals, Inc. · All companies